¿Tienes uno para vender? Vender en Amazon
Volver atrás Ir adelante
Escuchar Reproduciendo... Interrumpido   Estás escuchando una muestra de la edición de audio Audible.
Más información
Ver esta imagen

Pharmaceutical Innovation, Competition and Patent Law: A Trilateral Perspective (Inglés) Tapa dura – 30 jul 2013


Ver los 2 formatos y ediciones Ocultar otros formatos y ediciones
Precio Amazon
Nuevo desde Usado desde
Tapa dura
EUR 231,45
Tapa dura, 30 jul 2013
EUR 312,99 EUR 173,55
click to open popover

Descripción del producto

Críticas

`This is an intriguing selection of topical essays addressing fundamental questions of pharmaceutical innovation. It is comprised of a high-profile list of contributors, including academics, judges and practitioners from the U.S., Europe and Japan, who "explore to what extent patent strategies and life-cycle management practices take advantage of patent laws and health-care regulation and disrupt the necessary balance between incentives for innovation and access to affordable medicines and health care". . . This is an enjoyable, readable and interesting book containing thorough studies of "hot" legal issues in the pharma sector converging in an decisive era for pharmaceutical innovation. It ought to be found in any library that has reserved space for pharma-, IP- or competition law-related literature.' -- Jur. Dr. Timo Minssen, European Competition Law Review `In sum, the book is well written, interesting and very topical. It is written by very knowledgeable lawyers, which is reflected in the high quality of the articles. . . I recommend this book, not only for academics but for practicing lawyers as well. Many of the contributions contain valuable ``take home messages'', which should be taken into account in the discussions.' -- Marcus Norrgard, International Review of Intellectual Property and Competition Law

Reseña del editor

Public health, safety and access to reasonably priced medicine are common policy goals of pharmaceutical regulations. As both the context for innovation and competitive structure change, industry actors dynamically challenge the balance between the incentive for protection and the achievement of those policy goals. Considering the arguments from the perspectives of innovation, competition law and patent law, this book explores the difficult question of balancing protection with access, highlighting the difficulties in harmonization and coordination. The contributors to this book, including academics, judges and practitioners from Europe, the US and Japan, explore to what extent patent strategies and life-cycle management practices take advantage of patent laws and health-care regulation and disrupt the necessary balance between incentives for innovation and access to affordable medicine and health care. Addressing fundamental questions in the field of pharmaceutical innovation, this book will appeal to scholars and practitioners in intellectual property, competition law and life sciences regulation, as well as pharmaceutical companies and regulators.

Ver Descripción del producto

No es necesario ningún dispositivo Kindle. Descárgate una de las apps de Kindle gratuitas para comenzar a leer libros Kindle en tu smartphone, tablet u ordenador.

  • Apple
  • Android
  • Windows Phone

Obtén la app gratuita:



Detalles del producto


Opiniones de clientes

No hay opiniones de clientes
Comparte tu opinión con otros clientes